of particular interest to the reported occurrence of diarrhoea with cimetidine therapy is the finding in the bacteriological studies of intestinal aspirates and biochemistry estimations for indicanuria in the consenting patients which showed that orally administered cimetidine 1g daily for 4 weeks neither produced demonstratable alterations in the bacterial content of the small bowel not pathological indicanuria , thereby excluding bacterial overgrowth syndrome as a therapeutic hazard in the clinical application of cimetidine .
C0021853
intestinal
C0005750
bacterial